Could a diabetes pill ease MS nerve pain? early trial launches.
NCT ID NCT07221799
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 26 times
Summary
This early-phase study tests whether a diabetes drug called glibenclamide (glyburide) can safely reduce nerve pain in people with multiple sclerosis. Ten adults with MS and neuropathic pain will take the oral extended-release drug, and researchers will monitor safety, drug levels, and pain scores. The goal is to see if the drug is well-tolerated and worth studying further for pain relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROPATHIC PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Maryland School of Medicine
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.